English

Interim Report January - March 2008

Report this content

• Group income from sales of goods and royalties amounted to 289 (300) MSEK.

• Operating income amounted to 10 (56) MSEK.

• Revenues within the Esthetics product area amounted to 233 (240) MSEK and operating income was 55 (88) MSEK.

• Net income after tax amounted to 10 (42) MSEK.

• Earnings per share amounted to 0.10 (0.42) SEK.

• As from April 1, 2008 all North American insurance companies reinsure endoscopic treatment of VUR (Deflux®).

Documents & Links